Stock analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report released on Wednesday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
Shares of NYSE:AMPE opened at $0.00 on Wednesday. The company has a market cap of $2,394.00, a PE ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $2.47. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.01.
About Ampio Pharmaceuticals
Read More
- Five stocks we like better than Ampio Pharmaceuticals
- What Investors Need to Know About Upcoming IPOs
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Use the MarketBeat Stock Screener
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
